| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
ARTICLES |
q/111
Section of Endocrinology, Childrens Mercy Hospital, University of Missouri-Kansas City School of Medicine and the School of Pharmacy, University of Missouri-Kansas City, Kansas City, Missouri 64108
Address all correspondence and requests for reprints to: Jill D. Jacobson, M.D., Section of Endocrinology, Childrens Mercy Hospital, 2401 Gillham Road, Kansas City, Missouri 64108. E-mail: jjacobson{at}cmh.edu
We have previously demonstrated that GnRH and its analogues modulate
the severity of murine systemic lupus erythematosus. In the
present study, we demonstrate that GnRH alters disease severity in a
sexually dimorphic fashion, even in gonadectomized mice. GnRH
administration leads to an exacerbation of lupus in ovariectomized
females, whereas it exerts no effect in castrated males. We initially
hypothesized that gender differences in lymphocytic expression of GnRH
receptor might explain these observations. Using competitive RT-PCR and
binding studies to quantitate GnRH receptor expression in lymphoid
organs, we found that GnRH administration led to decreased expression
of GnRH receptor messenger RNA (mRNA) and GnRH binding, compared with
vehicle, in spleens of ovariectomized females after 2 weeks of
treatment. These decreases occurred concurrently with increased
expression of interleukin-2 receptor mRNA and protein in females. GnRH
administration did not alter GnRH receptor or interleukin-2 receptor
mRNA or protein in castrated males. GnRH exerts actions on the
pituitary through G protein signal transduction, specifically through
G
q/11. Competitive RT-PCR revealed that GnRH
administration was associated with increases in the expression of
G
q/11 mRNA, compared with vehicle, in spleens in
ovariectomized females but not in castrated males. Immunoblot analysis
revealed a similar pattern. We conclude that gender differences in
expression of G
q/11 may contribute to gender differences
in immunity and/or autoimmune disease.
This article has been cited by other articles:
![]() |
K. D. Salazar, M. R. Miller, J. B. Barnett, and R. Schafer Evidence for a Novel Endocrine Disruptor: The Pesticide Propanil Requires the Ovaries and Steroid Synthesis to Enhance Humoral Immunity Toxicol. Sci., September 1, 2006; 93(1): 62 - 74. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. D. Jacobson and M. A. Ansari Immunomodulatory Actions of Gonadal Steroids May Be Mediated by Gonadotropin-Releasing Hormone Endocrinology, January 1, 2004; 145(1): 330 - 336. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. A. Ansari, M. Dhar, S. Spieker, N. Bakht, A. M. Rahman, W. V. Moore, and J. D. Jacobson Modulation of Diabetes with Gonadotropin-Releasing Hormone Antagonists in the Nonobese Mouse Model of Autoimmune Diabetes Endocrinology, January 1, 2004; 145(1): 337 - 342. [Abstract] [Full Text] [PDF] |
||||
![]() |
C C Mok and C S Lau Pathogenesis of systemic lupus erythematosus J. Clin. Pathol., July 1, 2003; 56(7): 481 - 490. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. D. Dixit, H. Yang, V. Udhayakumar, and R. Sridaran Gonadotropin-Releasing Hormone Alters the T Helper Cytokine Balance in the Pregnant Rat Biol Reprod, June 1, 2003; 68(6): 2215 - 2221. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |